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Abstract
China’s estimated 114 million people with diabetes pose a massive challenge for China’s health policy-makers 
who have significantly extended health insurance coverage over the past decade. What China is doing now, 
what it has achieved, and what remains to be done should be of interest to health policy-makers, worldwide. We 
identify the challenges posed by China’s two principal strategies to tackle diabetes: (1) A short-term pilot strategy 
of health promotion, detection and control of chronic diseases in 265 national demonstration areas (NDAs); and 
(2) A long-term strategy to extend health promotion and strengthen primary care capacity and health system 
integration throughout China. Finally, we consider how Chinese innovations in artificial intelligence (AI) and 
Big Data may contribute to improving diagnosis, controlling complications and increasing access to care. Health 
system integration in China will require overcoming the fragmentation of a system that still places excessive 
reliance on local government financing. Moreover, what remains to be done resembles deeper challenges faced 
by healthcare systems worldwide: the need to upgrade primary care and reduce inequalities in access to health 
services. 
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Introduction
China accounts for the largest number of people with diabetes 
(114 million),1 mainly type 2, within a single nation. This 
poses a massive challenge for China’s policy-makers who have 
significantly extended health insurance coverage over the 
past decade. Medical management of diabetes, alone, before 
complications, is already estimated to account for 8.5% of 
national health expenditure in China.1-3 As Professor Linong 
Ji, Vice President of the International Diabetes Federation 
averred, if diabetes is not controlled in China, “the wealth that 
we’ve accumulated over the past 30 years will be wasted in the 
drains of our dialysis machines.”4 
What China is now doing, what it has achieved, and what 
remains to be done, can be instructive for health policy-
makers, worldwide. Based on journal articles in Chinese, 
government sources and peer-reviewed research articles, 
in English, we review prevalence estimates, variations by 
geographic areas, and assess China’s accomplishments and 
the two principal strategies it has implemented to date: (1) A 
short-term pilot strategy of health promotion, detection and 
control of chronic diseases in 265 national demonstration 
areas (NDAs); and (2) A long-term strategy to extend health 
promotion and strengthen primary care capacity and health 
system integration among local communities and health 
providers, including hospitals, throughout China. We also 
consider how Chinese innovations in artificial intelligence 
(AI) and Big Data may contribute to health promotion, 
detection and management of diabetes in the future. 
Diabetes Prevalence: National Average and Variations
Prevalence estimates of disease are highly dependent on 
the assumptions, definitions and survey methods used, all 
of which require judgment calls and interpretation. Thus, 
it is not surprising that five recent surveys, in China, arrive 
at different estimates of diabetes prevalence (Table 1). 
Although these surveys were conducted at different times, 
the differences may also reflect different methods (including 
selection of areas and samples, sample size, blood glucose 
testing indicators, population age structure) rather than 
disease prevalence. For example, the 1994 survey5 was not 
based on a nationally representative sample and the two most 
recent surveys (2010 and 2013)6,7 apply 2010 criteria from the 
American Diabetes Association’s (ADA’s) definition, while the 
2007-2008 and 1994 surveys applied more restrictive criteria 
from the World Health Organization (WHO).5,8
Even after taking into account methodological differences 
among these surveys, the four-fold growth in diabetes 
prevalence since 1994 is striking (Table 1).5,7 The socio-
economic and cultural determinants of this growth are 
most often attributed to the transformation of diet,10 genetic 
factors,11 the effects of the Great Famine (1958-1962)12,13 
and its intergenerational effects.13 In Chinese megacities, 
children are typically raised by their grandparents, most of 
whom experienced the famine. This experience has likely 
contributed to their high-calorie intake and low physical 
activity, and in this way exacerbated the intergenerational 
transmission of risk factors for diabetes.
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Another striking finding from the surveys is the low share 
of people with diabetes who are aware of their illness (the 
detection rate), a significant indicator since diabetes patients 
who do not control their blood sugar levels are likely to end 
up with cardiovascular disease or kidney failure. The most 
recent survey7 indicates a 36.5% detection rate in 2013, 
which is much lower than in France (67.24%),14 the United 
States (75.65%),15 the United Kingdom (83.55%),16 Australia 
(71%),17 and India (47.98%).18
Geographic Variation 
There are enormous variations in diabetes prevalence among 
urban and rural areas and wealthy and poorer regions. In 
2016, urban versus rural residents’ annual income (33 616 
yuan) was almost 3 times that of their rural counterparts 
(12 363 yuan).19 Based on the 2010 survey, prevalence of 
diabetes ranges from 14.3% in urban versus 10.3% in rural 
areas.6 Higher-income urban counties have a higher average 
prevalence rate (13.1%), than rural low-income counties 
(8.7%)20; or according to a 2013 survey, 12.6% in urban 
versus 9.5% in rural areas.7 Based on a 2010 survey, adults 
with diabetes living in rural areas are less likely to be aware 
of their illness (38.7%) than their counterparts in urban areas 
(24.6%)6; according to another 2010 survey, the detection 
rate ranges from 40.8% in higher-income urban counties to 
20.5% in lower-income rural counties20; according to the 2013 
survey, 43.1% in urban and 29.1% in rural areas.7 In general, 
people residing in wealthier urban areas are more likely to 
have diabetes. Among the poorest populations in these areas, 
however, due to a lower level of health awareness, they face 
lower odds of having their condition detected and managed.20 
Migrant Workers and Urban-Rural Variation
China has experienced the world’s most rapid urbanization 
over the past two decades. Attracted by higher wages, millions 
of rural residents have migrated to cities. Those who have left 
their hometown for more than 6 months and have not been 
able to register as official residents in cities are considered 
migrant workers. Although their number has declined from 
a peak of 253 million (in 2014), to 245 million migrants (in 
2016),21 they still pose a public health challenge since most 
municipal governments regard them as outsiders and their 
health insurance benefits (from home provinces) are typically 
insufficient to assure them of access to healthcare in cities. 
Although migrant workers face fewer risk factors for 
diabetes, since most healthy migrants participate in heavy 
labor,22 once they become diabetic, or even prediabetic, they 
are more likely to forgo medical care due to financial barriers 
than official urban residents.23 Since diabetes is associated 
with increased mortality from a range of complications, their 
health status is likely to deteriorate faster than that of their 
official urban counterparts.22 Given the low diabetes detection 
rates (Table 1) and the low treatment rates for those diagnosed 
with diabetes, there is evidence of excess mortality of diabetes 
patients, which points to inadequate health promotion and 
clinical management of diabetes.24,25 
National Strategies: Achievements and Problems
In the Healthy China 2030 Plan, approved by the State 
Council and the Party’s Central Committee, diabetes, along 
with cancer, hypertension, and cardiovascular diseases, are 
listed as the four major non-communicable diseases (NCDs) 
for which the goal is to “control the prevalence and reduce 
the probability of early death.”26 Also, in 2017, the central 
government launched a 2017-2025 plan to control NCDs, 
which includes increasing the regular monitoring and self-
management rate for diabetes patients from 50% (which 
is probably an overestimate) to 70% by 2025.27 To achieve 
population behavior change in any society is a difficult 
task; it is all the more so in large and diverse countries like 
China. Two national strategies, in particular, deserve special 
attention.
National Demonstration Areas: A Short-term Strategy
Since 2010, the Chinese Ministry of Health has established 
a network of 265 NDAs to develop pilot projects for health 
promotion, detection and control of chronic diseases. To 
qualify for an NDA, county governments applied for central 
Table 1. National Surveys of Diabetes in China
Year of the Survey Prevalence Estimate (%) Detection Rate (Patients Aware of Their 
Condition) (%)
Prediabetes Prevalence 
Estimate (%)
Source
1994a 2.51 29.6 3.23 Pan et al, 19975
2000-2001b 5.49 - 7.33 Hu et al, 20099
2007-2008c 9.7 39.3 15.5 Yang et al, 20108
2010d 11.6 30.1 50.1 Xu et al, 20136
2013e 10.9 36.5 35.7 Wang et al, 20177 
a A survey based on a sample of 250 000 adults aged 25 years or older, in 19 areas, including cities and rural areas of the north, south, east, west, and middle 
part of China. Diagnostic criteria from WHO, 1985.
b A survey based on a population of 19 012 adults, aged 35-74 and randomly selected from 20 primary sampling units (street districts in urban areas, townships 
in rural areas) and invited to participate. Diagnostic criteria from ADA.
c A survey based on a nationally representative sample of 46 239 adults, 20 years of age or older, from 14 provinces and municipalities participated in the study. 
Diagnostic criteria from WHO, 1999.
d A cross-sectional survey in a nationally representative sample of 98 658 adults. Diagnostic criteria from the ADA, 2010.
e A nationally representative cross-sectional survey of 170 287 adults; minority ethnic groups in China with at least 1000 participants (Tibetan, Zhuang, Manchu, 
Uyghur, and Muslim) were compared with Han participants. Diagnostic criteria from the ADA, 2010.
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government subsidies and agreed to follow strict protocols. 
As of 2015, 9.29% of China’s counties established NDAs 
under the responsibility of China’s Center for Disease 
Control (CDC). At the county level, various local government 
departments (propaganda, women’s federation, education, 
health) are involved and in most cases the top county official 
is responsible for overall coordination. Primary care providers 
promote education and self-management of health conditions 
through appropriate dietary changes, control of tobacco use, 
and physical activity.28 
A 2018 evaluation on the implementation of NDAs 
compared the 265 NDAs to one another along multiple 
criteria to assess their effectiveness in managing patients with 
diabetes and other NCDs.29 Aside from disparities across 
the NDAs, it found that health promotion activities and 
monitoring general population health were generally more 
successful than managing the conditions of those suffering 
from NCDs. With regard to diabetes, this conclusion most 
probably applies to all of China as it is consistent with the 
findings of Bragg and colleagues on the high proportion of 
deaths attributed to diabetic ketoacidosis or coma and chronic 
kidney disease mainly related to diabetes.24 These deaths are 
usually related to poor clinical management. 
Another 2018 evaluation of the NDAs, specifically on the 
management of patients with diabetes, by Jin and colleagues, 
suggests that health promotion efforts resulting in lifestyle 
changes and self-management can nevertheless improve 
process measures of diabetes control.30 This study, conducted 
in 2016, on 3213 randomly selected adult residents (35 years 
and over) in NDAs, found that, among patients diagnosed with 
diabetes, 69.92% were assigned to a general practitioner (GP) 
and 53.66% reported receiving standardized management 
for their condition – at least one blood glucose test and four 
follow-up visits, per year, by a GP. It found that patients who 
are assigned to a GP, have a more positive attitude, and that 
patients without hypertension, are more likely to have their 
diabetes under better standardized control, ie, with patients 
receiving at least one blood glucose test and four follow-up 
visits, per year, by a GP. The study also found that patients 
in eastern provinces are under better standardized control, 
which could be the result of earlier establishment of NDAs; 
or alternatively, could be attributed to better health systems in 
these provinces.30 While the results of NDAs are encouraging, 
they also highlight the need for greater centralization of 
funding for public health interventions. The 2018 plan 
indicates that health spending has depended largely on local 
governments, which explains the wide disparities in access to 
health services among counties.31 
Jin and colleagues conclude that “NDAs have achieved the 
goals of the 2012-2015 National NCD Control Plan, which 
requires a 40% standardized management rate.”30 They also 
find that 79.54% of patients in their study were aware of their 
diabetes diagnosis and 83.2% were in taking prescription 
drugs regularly to control their blood glucose levels. Both of 
these figures are high for China which suggests that NDAs 
have produced significant effects. It is difficult, however, to 
interpret these figures for several reasons. First, there were 
no control groups in this study – neither cross-sectional, nor 
before and after the intervention. They relied on comparisons 
with other national surveys that may not be comparable to 
theirs. Second, their survey question on self-reported high 
blood sugar levels is ambiguous. It is not sufficient to confirm 
the diagnosis and may include prediabetes patients. In fact, 
Jin and colleagues suggest that further surveys be conducted 
to see if standardized management has affected blood sugar 
control. Thus, we believe that this evaluation must be read 
with caution. Nonetheless, the NDAs represent important 
pilots for learning about disparities in prevalence, awareness 
and treatment of diabetes. Moreover, they are important 
for testing health promotion and monitoring tools, self-
management and standardized management approaches for 
controlling diabetes.
Health System Integration: A Long-term Strategy
Beyond the importance of pilot projects, the long-term 
strategy for confronting the diabetes challenge in China is to 
extend efforts at health promotion, detection and control of 
diabetes while simultaneously integrating academic medical 
centers (AMCs) and other hospitals with effective primary 
care. AMCs are overcrowded with patients who have simple 
conditions, while the primary care system is under-equipped 
with basic medical infrastructure and an under-qualified 
workforce. Since 2015, the State Council encouraged health 
system integration by promoting what the Chinese call a 
“hierarchical medical system,”32 a policy that attempts to 
attract more patients to primary health centers before going 
to AMCs. 
The aspiration to achieve health system integration, in 
China, is as daunting as in any other health system. Moreover, 
China faces two significant obstacles. First, most primary 
care institutions are not qualified enough to earn patients’ 
trust. In 2017, 82% of physicians and assistant physicians in 
rural township health centers and 55% in urban community 
health centers have no bachelor’s degree, in contrast to 70% of 
their counterparts in hospitals[1].2 In the absence of uniform 
professional standards, it is rational for patients to crowd into 
the best hospitals. Second, under the current system, hospitals 
have more abundant supplies of prescription drugs, partly 
because selling them is still an important part of hospital 
revenue. Although overcrowded, AMCs have little incentive 
to divert patients to primary care institutions. 
In confronting these obstacles, municipal governments in 
big cities are attempting to integrate AMCs and community 
clinics into so-called medical partnerships. There are several 
models for achieving such health system integration. Some 
partnerships share only the same referral system; others have 
actually achieved deeper cooperation such that different 
institutions share the same workforce and operate under the 
same leadership. In general, cooperation is stronger in big 
cities than in rural areas. Shenzhen’s Luohu model is an example 
of high-level of cooperation where primary care institutions 
and AMCs form a “hospital group” under the leadership of 
a common board of directors. Medical partnerships in big 
cities often resemble the Luohu model, though the level of 
cooperation varies.33
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The Future 
Although the implementation of NDAs and efforts to achieve 
health system integration are both well-conceived and 
necessary steps to confront the challenge of diabetes and 
more generally achieve China’s goals for healthcare reform, 
these interventions have so far been inadequate. Two deeper 
long-term challenges remain before significant progress can 
be made in stemming the diabetes crisis: upgrade the primary 
care workforce; and reduce inequalities in access to healthcare. 
The Primary Care Workforce
Long-term management of diabetes requires a competent 
primary care workforce backed up by available resources. 
However, these requirements are not yet met in China, 
neither for people with diabetes nor for the general 
population. Five percent of urban community health centers 
and 10% of township (rural) health centers are unable to 
provide basic services such as routine blood tests, urinalyses 
and electrocardiography. For village clinics, 96% are unable 
to provide routine blood tests, 90% are unable to provide 
urinalyses, and 31% are unable to provide blood glucose tests. 
Only 46% of patients with diabetes who usually seek care from 
primary healthcare institutions are diagnosed, and only 3% of 
them have their blood glucose controlled. Among all patients 
treated by primary care institutions, 84% are not satisfied and 
39% of patients who bypassed primary care institutions noted 
their distrust as the reason for their choice.34 
In 2016, the ratio of certified GPs per 10 000 population 
was 1.6, far below high-income countries’ average (Table 2). 
As China has sought to improve health system integration 
through the rapid expansion of the primary care workforce, 
the number of certified GPs has increased by 34% but the 
physician workforce in hospitals increased faster (by 57%) 
than urban (15%) and rural (37%) primary care institutions.2
Unfortunately, GPs in China remind the population of 
barefoot doctors in the Mao era, during which professional 
standards of medicine were severely compromised to 
achieve universal coverage of basic necessities. Due to 
the transformation of China’s healthcare system over the 
past decades, the term “doctor” refers to a wide range of 
professionals, from village doctors with months of training 
to graduates of the best medical schools.36 Although China is 
trying to reestablish professional standards through reforms 
in medical education, it will take time before the profession of 
GP becomes an attractive one for medical students and wins 
the trust of patients.
Inequalities in Access to Healthcare
Despite the proclaimed commitment to universal health 
coverage, as we noted earlier, the vast majority of China’s 
migrants are covered by their home provinces, which provide 
them much less generous insurance coverage than their 
resident cities. Though efforts have been made to increase 
reimbursement in their resident cities, due to administrative 
barriers, it is still difficult for migrant workers to pay out-
of-pocket for healthcare and then wait to be reimbursed a 
small share of their outlays.37 This situation is most severe 
in large cities with the highest prevalence of migrants and 
diabetes. For example, almost a third of Beijing’s 21.71 million 
residents (8.08 million) do not have an urban residence card 
(hukou).38 The same situation prevails in Shanghai where 
9.7 million residents, of its 24.2 million inhabitants, have no 
urban residence card.39 
In these wealthy cities, since migrants are, on average, 
living in more precarious conditions, less educated, and less 
attentive to potential health problems, they tend to have higher 
than average rates of overweight and obesity and alcohol 
consumption. Their risk of diabetes is therefore higher than 
that of their official urban counterparts.22 Despite these well-
recognized problems, the Beijing and Shanghai 2030 Health 
Plans do not include specific measures for diabetes control 
among migrants.40,41
Artificial Intelligence and Big Data 
Beyond the importance of taking action on health promotion 
strategies to improve diet, encourage exercise and increase 
greater awareness of risk factors for diabetes, China’s health 
policy-makers have not overlooked significant advances in 
AI and Big Data.42 In some respects, the future is already 
here with respect to automated retinal screening (detection 
of diabetic retinopathy), clinical decision support (detection 
and monitoring of diabetes and comorbidities), predictive 
population risk stratification (identification of diabetes 
subpopulations at higher risk of complications) and patient 
self-management tools (eg, activity and dietary tracking 
devices and AI-improved glucose sensors). As these tools 
are improved, they will soon enable health professionals in 
China to identify some prediabetic patients and to diagnose 
complications related to diabetes such as retinopathy and 
renal diseases.43 On-going research on specific algorithms 
may also eventually allow more personalized targeting of 
diabetes treatment.44
Today, diabetes patients are generally more “connected” 
than patients with other chronic conditions. Activity trackers 
and smartphone applications have the potential to prevent 
type 2 diabetes by promoting the adoption of behaviors that 
prevent the onset of the disease, such as physical activity and 
dietary changes. Also, use of connected sensors or mobile 
applications already allow better daily monitoring of patients 
with type 2 diabetes.45 In addition to introducing innovations 
Table 2. Primary Care Workforce: China and Other Countries, 2016
GPs (Per 1000 Population) Nurses (Per 1000 Population)
China 0.16 2.32
Korea 0.13 6.80
Japan - 11.34
US 0.31 11.61
Australia 1.17 11.57
UK 0.76 7.88
Canada 1.27 9.91
France 0.90 10.21
Germany 0.70 12.84
Abbreviation: GPs, general practitioner.
Source: National Commission of Health and Family Planning Statistical 
Yearbook3 and OECD data.35
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such as intelligent sensors for measuring and treating blood 
glucose levels, Ali Health, the medical branch of the giant 
Alibaba launched an AI physician system, Dia Doc, in May 
2018. This system, dedicated to diabetes, brings together 
experienced specialists and practitioners, and guides GPs 
less familiar with the disease in performing diagnosis and 
treatment.46
China’s digital transformation and its massive amounts 
of accumulated data provide an opportunity for the health 
system to leverage AI capabilities in improving diabetes care.47 
Diet and exercise, two fundamental risk factors for most 
NCDs, are under the surveillance of Chinese tech-giants. 
E’leme (Are You Hungry?), a takeaway app recently acquired 
by the top tech-giant, Alibaba, has 260 million users, and Ali 
has already been collecting data on its users’ diets for years.48 
Ali’s competitor Tencent, whose most successful app, WeChat 
has 1.08 billion users who use it at least once a month,49 has 
been collecting data on the average number of steps, per day, 
walked by the Chinese.50 
Drawing on their subsidiary payment systems, Alipay and 
WeChat Pay, both Ali and Tencent are capable of analyzing 
nearly all aspects of the population’s economic activities. Their 
ambition clearly extends beyond expanding membership, for 
health improvement strategies present a most desirable new 
frontier, especially since the government is encouraging the 
use of Big Data in the Healthy China 2030 development plan.26 
Health was one of the top priorities in the government’s plan 
to promote the use of Big Data and encourage cooperation 
among technology enterprises as a way to confront diabetes 
and other NCDs.51 Premier Li Keqiang, himself, has flagged 
Big Data as an area from which the public health sector 
should learn.52
Concluding Observations
Faced with the world’s largest population of people 
with diabetes that continues to grow with China’s rapid 
urbanization, China has significantly improved the detection 
and management of diabetes, with its pilot projects in NDAs 
and its attempts to improve health system integration. These 
initiatives demonstrate a willingness to confront the rise of 
diabetes with strategies based on health promotion, disease 
detection and management of the multiple conditions and 
complications associated with the disease. AI and Big Data 
are likely to improve diagnosis and treatment. However, there 
is no nation in which the challenge of diabetes is likely to be 
solved by a technological fix. AI and Big Data must be financed 
and embedded in an institutional health system. Based on 
the literature and data we have reviewed and analyzed in this 
paper, significant challenges remain.
The extension to the rest of China of lessons learned from 
short-term strategies implemented in NDAs will require 
overcoming the fragmentation of a health system that still 
places excessive reliance on local government financing. 
Ongoing reform of the health system will require greater 
efforts to train and pay primary care providers to relieve a 
system that is too focused on large hospitals, and to achieve 
broader health system integration. Above all, longer-term 
success in meeting the challenge of diabetes will have to 
focus on upgrading the primary care workforce and reducing 
inequalities in access to healthcare. 
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Endnote
[1] In China, healthcare institutions are categorized as hospitals, urban community 
health centers and rural township health centers. Urban community and rural 
township health centers are considered as primary care institutions, but they 
also provide inpatient care. The yearbook does not provide strict and clear 
definitions but it is generally believed that hospitals provide comprehensive 
care while urban and rural health centers are smaller than hospitals and provide 
mainly primary care.
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